:

FINTECH FUNDING HITS $28.6B IN H1 2026, UP 23% YOY

INDUSTRY DESK1 MIN READ
THU, JUL 16, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Venture funding into fintech startups grew 22.7% year-over-year to $28.6B globally in the first half of 2026. However, deal count dropped 25.7% and funding declined 17.3% compared to H2 2025's $34.6B.

The fintech sector shows mixed signals as 2026 progresses. While year-over-year growth remains solid at nearly 23%, the sequential decline from the second half of 2025 indicates a cooling investment environment. The divergence between funding growth and deal count underscores a consolidation trend: fewer deals are receiving larger checks. This suggests venture investors are concentrating capital on later-stage companies or those with stronger fundamentals. The drop from $34.6B in H2 2025 to $28.6B in H1 2026 represents a notable contraction within six months. Despite the YoY gains, the quarter-to-quarter decline signals caution among investors entering the latter half of 2026. The 25.7% fall in deal count—sharper than the 17.3% funding decline—indicates that average deal size has increased, reflecting investor selectivity in a maturing fintech landscape.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Retro, a friend-focused photo-sharing app founded by former Instagram employees, has secured $21 million in Series A funding. The capital injection signals investor confidence in the social app's differentiated approach to photo sharing.

1H AGOIndustry Desk

Sweden has built one of Europe's most vibrant startup ecosystems, drawing attention from investors and entrepreneurs across the continent. Cherry Ventures general partner Sophia Bendz breaks down the factors driving the Nordic nation's tech boom.

1H AGOIndustry Desk

Metriport secured $26M in Series A and seed funding led by Matrix GP, bringing its total funding to $28.4M. The startup provides tools that enable doctors to retrieve and manage patient data.

4H AGOAI Desk

Faro, an AI platform for clinical trial optimization, closed a $37.3 million Series B round co-led by Merck Global Health Innovation Fund and S32. The funding will support development of data models and AI tools designed to streamline trial processes.

4H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.